BRIEF-Emd Serono - Co, Pfizer Canada Announce Health Canada Approval For Bavencio For Treating Metastatic Merkel Cell Carcinoma In Previously Treated Adults

By: Reuters: Company News

February 23, 2018 at 05:32 AM EST

* EMD SERONO - CO, PFIZER CANADA ANNOUNCE HEALTH CANADA APPROVAL FOR BAVENCIO FOR TREATING METASTATIC MERKEL CELL CARCINOMA IN PREVIOUSLY TREATED ADULTS Source text for Eikon: Further company coverage:

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.